日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation

经鼻内递送工程化抗SARS-CoV-2细胞外囊泡可有效抑制肺部感染和炎症。

期刊:Drug Delivery and Translational Research
影响因子:5.5
doi:10.1007/s13346-025-01922-9
Idris, Adi; Shrivastava, Surya; Gao, Wenqing; Supramaniam, Aroon; Tayyar, Yaman; West, Nicholas P; Kelly, Gabrielle; Acharya, Dhruba; McMillan, Nigel A J; Morris, Kevin V
SARS-CoV-2
炎症
炎症/感染
囊泡
细胞生物学
发表日期：2025
文献求助 收藏

Extracellular Vesicles Loaded with Long Antisense RNAs Repress Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

含有长链反义RNA的细胞外囊泡抑制严重急性呼吸综合征冠状病毒2感染

期刊:Nucleic Acid Therapeutics
影响因子:4.7
doi:10.1089/nat.2023.0078
Idris Adi, Shrivastava Surya, Supramaniam Aroon, Ray Roslyn M, Shevchenko Galina, Acharya Dhruba, McMillan Nigel A J, Morris Kevin V
细胞生物学
囊泡
发表日期：2024
文献求助 收藏

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection

预防性鼻内给药脂质纳米颗粒制剂的siRNA可降低SARS-CoV-2和RSV肺部感染。

期刊:Journal of Microbiology Immunology and Infection
影响因子:3.7
doi:10.1016/j.jmii.2023.02.010
Supramaniam, Aroon; Tayyar, Yaman; Clarke, Daniel T W; Kelly, Gabrielle; Acharya, Dhruba; Morris, Kevin V; McMillan, Nigel A J; Idris, Adi
炎症/感染
SARS-CoV-2
发表日期：2023
文献求助 收藏

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants

核衣壳特异性诊断方法用于检测不同的SARS-CoV-2变异株

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.926262
Isaacs, Ariel; Amarilla, Alberto A; Aguado, Julio; Modhiran, Naphak; Albornoz, Eduardo A; Baradar, Alireza A; McMillan, Christopher L D; Choo, Jovin J Y; Idris, Adi; Supramaniam, Aroon; McMillan, Nigel A J; Muller, David A; Young, Paul R; Woodruff, Trent M; Wolvetang, Ernst J; Chappell, Keith J; Watterson, Daniel
SARS-CoV-2
发表日期：2022
文献求助 收藏

Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccine

通过单剂量皮肤贴片递送的SARS-CoV-2刺突蛋白疫苗提供全面保护

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.abj8065
McMillan, Christopher L D; Choo, Jovin J Y; Idris, Adi; Supramaniam, Aroon; Modhiran, Naphak; Amarilla, Alberto A; Isaacs, Ariel; Cheung, Stacey T M; Liang, Benjamin; Bielefeldt-Ohmann, Helle; Azuar, Armira; Acharya, Dhruba; Kelly, Gabrielle; Fernando, Germain J P; Landsberg, Michael J; Khromykh, Alexander A; Watterson, Daniel; Young, Paul R; McMillan, Nigel A J; Muller, David A
SARS-CoV-2
发表日期：2021
文献求助 收藏

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

一种针对SARS-CoV-2的siRNA纳米颗粒疗法用于治疗COVID-19

期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2021.05.004
Idris, Adi; Davis, Alicia; Supramaniam, Aroon; Acharya, Dhruba; Kelly, Gabrielle; Tayyar, Yaman; West, Nic; Zhang, Ping; McMillan, Christopher L D; Soemardy, Citradewi; Ray, Roslyn; O'Meally, Denis; Scott, Tristan A; McMillan, Nigel A J; Morris, Kevin V
SARS-CoV-2
发表日期：2021
文献求助 收藏

PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice.

PG545 治疗可降低 C57BL/6 小鼠中 RRV 引起的 AST、ALT 升高以及继发性淋巴器官改变

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0217998
Supramaniam Aroon, Bielefeldt-Ohmann Helle, Rudd Penny A, Webster Julie, Ferro Vito, Herrero Lara J
其它
发表日期：2019
文献求助 收藏

Chondrocytes Contribute to Alphaviral Disease Pathogenesis as a Source of Virus Replication and Soluble Factor Production

软骨细胞作为病毒复制和可溶性因子产生的来源，在甲病毒疾病的发病机制中发挥作用

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v10020086
Lim, Elisa X Y; Supramaniam, Aroon; Lui, Hayman; Coles, Peta; Lee, Wai Suet; Liu, Xiang; Rudd, Penny A; Herrero, Lara J
微生物学
细胞生物学
发表日期：2018
文献求助 收藏